Garo H. Armen, Director at MiNK Therapeutics, Inc. (INKT), sold 100,000 shares at $0.95 ($95K) on 2023-05-05, disclosed to the SEC on 2023-05-05.
Open-market sale of $95k INKT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTIX | BUY | 2026-08-20 | $10K | — | Filing → |
| PTIX | BUY | 2026-08-12 | $710 | — | Filing → |
| PTIX | BUY | 2026-08-10 | $151 | — | Filing → |